Potential Role of VHL, PTEN, and BAP1 Mutations in Renal Tumors

Krisztián Szegedi1,2, Zsuzsanna Szabó3, Judit Kállai4

  • 1Department of Urology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.

PubMed

Insights

Genetic analysis of renal tumors revealed VHL gene mutations in 25% of samples, suggesting a potential role in renal cancer development. However, overall mutation rates were low, indicating complex genetic factors influence disease progression.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Renal tumors exhibit genetic heterogeneity with common structural changes.
  • Mutations in VHL, PTEN, and BAP1 genes are frequently observed in renal tumors.
  • The clinical significance of these mutations requires further investigation.

Purpose of the Study:

  • To investigate the mutation frequency and clinical relevance of VHL, PTEN, and BAP1 genes in a cohort of renal tumor patients.
  • To identify potential genetic markers associated with renal tumor development.

Main Methods:

  • DNA sequencing of 24 renal tumor samples.
  • Analysis of mutations and genetic polymorphisms in VHL, PTEN, and BAP1 genes.

Main Results:

  • VHL gene mutations were detected in 25% of samples, with specific instances in AML and oncocytoma.
  • PTEN gene mutations were rare (one sample), and BAP1 showed no mutations (all wild-type).
  • One genetic polymorphism (rs779805) was identified in VHL.

Conclusions:

  • VHL and PTEN mutations may contribute to human renal cancer development.
  • The overall mutation rate for these genes was low, suggesting other genetic alterations are involved.
  • Disease development and prognosis are not solely determined by VHL, PTEN, or BAP1 mutations.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K